Boosters and vaccinating children mean we’re relying on two pharmaceutical companies to supply Australia’s COVID vaccines. That needs to change.
We’re reliant on overseas supply - and the many moving parts of delivery. Each of those parts require staff on the ground – and many workers in this system are likely being affected by Omicron.
With enough vaccine supplies coming online from October, the government has no excuse not to have all arrangements in place for an efficient vaccination program. Here’s what needs to change.
There are tangible things we can do now to help people understand the benefits and possible risks of COVID-19 vaccination.
The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
Supply chain issues can be addressed – but the issues with the AstraZeneca vaccine are political, too.
Getting a vaccine is proving difficult for many older people now, but the mad rush for the vaccine won’t last long. Many people don’t want to get one at all, and that will impede herd immunity.
The vaccines’ cold storage requirements and shipment rules put small, rural communities at a disadvantage, but that’s only part of a long-running challenge.